Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
UBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...
Snowflake stock soaring has investors buzzing. This guide explains what's driving the rally, how to value the stock, ...
The Ethereum Foundation slashes staff by 54 and trims annual spending, triggering a leaner path for ETH. Robert Kiyos...
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
Berkshire Hathaway’s planned berkshire taylor morrison deal signals a shift toward an integrated housing platform, wi...
Could SpaceX stock reach $192 by 2027? This guide lays out the drivers, the math behind the target, and realistic ste...
Palantir has sparked debate among investors with rapid growth and high expectations. This guide breaks down whether p...
A rising demand for organ preservation and transplant networks could power meaningful upside in this healthcare infra...
A leading cybersecurity stock surged about 62% in 2026, propelled by artificial intelligence (ai) innovations. This a...
A family dispute highlights how large gifts to minors intersect with tax rules, saving goals, and the long arc of a y...
A 54-year-old engineer designs a $1.6 million income plan to yield about $9,500 per month by age 67, blending REITs, ...